XBI

Fund Description
The SPDR S&P Biotech ETF before expenses seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index (ticker: SPSIBITR).
Fund Profile
Fund Name SPDR S&P Biotech ETF
Fund Exchange Ticker XBI
Fund Sponsor State Street (SPDR)
Fund ISIN US78464A8707
Net Expense Ratio 0.35 %
Fund Inception Date 31 January 2006
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name S&P Biotech Index
Index Provider S&P DJ Indices
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 6 August 2020
Asset Under Management 5970.09 Million (USD)
1 Month Total Return -2.53 %
Year To Date Return 19.68 %
1 Year Total Return 36.60 %
3 Year Annualized Total Return 13.43 %
NAV 113.716
Share Outstanding 52,500,000
Top 10 Holdings (6 August 2020)
Constituent Name Constituent Ticker Constituent Type Weighting
NOVAVAX INC NVAX EQUI 0.0357763800
OPKO HEALTH INC OPK EQUI 0.0221940500
INVITAE CORP NVTA EQUI 0.0186353800
EMERGENT BIOSOLUTIONS INC EBS EQUI 0.0179658000
SORRENTO THERAPEUTICS INC SRNE EQUI 0.0167683600
INOVIO PHARMACEUTICALS INC INO EQUI 0.0151977100
AMICUS THERAPEUTICS INC FOLD EQUI 0.0136691100
IMMUNOMEDICS INC IMMU EQUI 0.0135887600
SAGE THERAPEUTICS INC SAGE EQUI 0.0134399600
NATERA INC NTRA EQUI 0.0131193700